Drug Type Gene therapy |
Synonyms Amyotrophic Lateral Sclerosis (Xalud) |
Target |
Mechanism IL-10 modulators(Interleukin-10 modulators) |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
RegulationOrphan Drug (US) |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Amyotrophic Lateral Sclerosis | Preclinical | US | 18 Aug 2024 |